Single Dose Intranasal Oxytocin and Cognitive Effects in Autism

Clinical trial NCT02493426 · COMPLETED

Trial details

NCT number: NCT02493426
Sponsor: University of Minnesota
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autism Spectrum Disorders

Start date: 2014-05-01
Primary completion: 2021-03-31
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.